• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered?肾素-血管紧张素-醛固酮系统阻断对肾移植受者的益处：结论已定还是仍有待解答？
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):691-693. doi: 10.2215/CJN.0000000000000479. Epub 2024 May 17.
2
Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.肾素-血管紧张素系统阻断与肾移植受者的长期临床结局：一项随机对照试验的荟萃分析。
Am J Kidney Dis. 2017 Jan;69(1):78-86. doi: 10.1053/j.ajkd.2016.08.018. Epub 2016 Oct 4.
3
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
4
Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.除血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂治疗外，盐皮质激素受体阻断：糖尿病肾病中的一种新兴模式：一项系统评价
Eur J Intern Med. 2014 Feb;25(2):173-6. doi: 10.1016/j.ejim.2013.11.007. Epub 2013 Dec 4.
5
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.阻断肾素-血管紧张素-醛固酮系统（RAAS）用于非瓣膜性心房颤动的一级预防：随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2013 Apr 30;165(1):17-24. doi: 10.1016/j.ijcard.2012.02.009. Epub 2012 Mar 14.
6
Aldosterone antagonists for preventing the progression of chronic kidney disease.用于预防慢性肾脏病进展的醛固酮拮抗剂。
Cochrane Database Syst Rev. 2014 Apr 29(4):CD007004. doi: 10.1002/14651858.CD007004.pub3.
7
Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.门诊开始使用环硅酸锆钠治疗后肾素-血管紧张素-醛固酮系统抑制剂的剂量：GALVANIZE RAASi真实世界证据研究
Adv Ther. 2025 Jun 18. doi: 10.1007/s12325-025-03254-z.
8
Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats.慢性肾素-血管紧张素-醛固酮系统抑制期间的心肾保护：证据和注意事项。
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):126-31. doi: 10.1093/ehjcvp/pvu023. Epub 2015 Mar 20.
9
Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis.比较肾素-血管紧张素-醛固酮阻断方案对长期化疗相关心脏功能障碍的影响：一项网状Meta分析
Cardiovasc Drugs Ther. 2025 Feb;39(1):171-186. doi: 10.1007/s10557-023-07457-w. Epub 2023 Jun 14.
10
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.

本文引用的文献

1
Effect of Spironolactone on Kidney Function in Kidney Transplant Recipients (the SPIREN trial): A Randomized Placebo-Controlled Clinical Trial.螺内酯对肾移植受者肾功能的影响（SPIREN 试验）：一项随机安慰剂对照临床试验。
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):755-766. doi: 10.2215/CJN.0000000000000439. Epub 2024 Feb 27.
2
Premature Death in Kidney Transplant Recipients: The Time for Trials is Now.肾移植受者的过早死亡：现在是进行试验的时候了。
J Am Soc Nephrol. 2022 Apr;33(4):665-673. doi: 10.1681/ASN.2021111517. Epub 2022 Mar 15.
3
OPTN/SRTR 2020 Annual Data Report: Kidney.OPTN/SRTR 2020 年度数据报告：肾脏。
Am J Transplant. 2022 Mar;22 Suppl 2:21-136. doi: 10.1111/ajt.16982.
4
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.肾移植后的肾功能、蛋白尿与心血管事件风险
Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.
5
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.稳定期肾移植受者的蛋白尿与移植物失败、心血管疾病事件和全因死亡：FAVORIT 试验的队列分析。
Am J Kidney Dis. 2019 Jan;73(1):51-61. doi: 10.1053/j.ajkd.2018.05.015. Epub 2018 Jul 20.
6
Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.雷米普利与安慰剂治疗蛋白尿肾移植患者的多中心、双盲、随机对照试验。
Lancet Diabetes Endocrinol. 2016 Apr;4(4):318-26. doi: 10.1016/S2213-8587(15)00368-X. Epub 2015 Oct 23.
7
Cardiovascular morbidity and mortality after kidney transplantation.肾移植后的心血管发病率和死亡率。
Transpl Int. 2015 Jan;28(1):10-21. doi: 10.1111/tri.12413. Epub 2014 Aug 20.
8
Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.预测肾移植后的冠心病：肾移植患者结局研究（PORT 研究）。
Am J Transplant. 2010 Feb;10(2):338-53. doi: 10.1111/j.1600-6143.2009.02949.x.
9
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.坎地沙坦可改善肾移植受者的血压控制并减少蛋白尿：来自 SECRET 的结果。
Nephrol Dial Transplant. 2010 Mar;25(3):967-76. doi: 10.1093/ndt/gfp581. Epub 2009 Nov 3.
10
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.肾移植后新发充血性心力衰竭：一种常见疾病，预后不良。
Am J Kidney Dis. 2005 Oct;46(4):720-33. doi: 10.1053/j.ajkd.2005.06.019.

Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered?

作者信息

Sawinski Deirdre, Mottl Amy K

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medical College, New York, New York.

Department of Transplantation Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, New York.

出版信息

Clin J Am Soc Nephrol. 2024 Jun 1;19(6):691-693. doi: 10.2215/CJN.0000000000000479. Epub 2024 May 17.

DOI:10.2215/CJN.0000000000000479
PMID:38758607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168816/
Abstract
摘要